Advertisement
Screener

CYTOKINETICS, INCORPORATED (CYTK) Graph

CYTK Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $28.62M; Research and development $97.81M; Selling, general and administrative $104.40M; Operating expenses $207.80M.
  • 2026-03-31: Revenue $19.36M; Research and development $95.53M; Selling, general and administrative $104.90M; Operating expenses $202.97M.
  • 2025-12-31: Revenue $17.75M*; Research and development $104.40M*; Selling, general and administrative (m); Operating expenses $196.12M*.
  • 2025-09-30: Revenue $1.94M; Research and development $99.23M; Selling, general and administrative (m); Operating expenses $168.69M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CYTK revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Collaboration Revenues$3.29MLicense AndMilestone Revenues$0.00Net Product Revenue$25.33MRevenue$28.62MOperating expenses$207.80MOperating income-$179.17MResearch & development$97.81MSelling, general& administrative$104.40MNet income-$198.76M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$28.62M$97.81M$104.40M$207.80M(m)-$198.76M
2026-03-31$19.36M$95.53M$104.90M$202.97M(m)-$206.03M
2025-12-31$17.75M*$104.40M*(m)$196.12M*(m)-$183.03M*
2025-09-30$1.94M$99.23M(m)$168.69M(m)-$306.18M
2025-06-30$66.77M$110.14M$65.72M$178.28M(m)-$134.37M
2025-03-31$1.58M$98.26M$57.37M$157.21M(m)-$161.38M
2024-09-30$463.00K$84.61M(m)$141.26M(m)-$160.54M
2024-06-30$249.00K$79.60M(m)$130.42M(m)-$143.32M
2024-03-31$835.00K$81.57M(m)$127.07M(m)-$135.64M
2023-09-30$378.00K$82.53M(m)$122.64M(m)-$129.42M
2023-06-30$867.00K$83.19M(m)$122.92M(m)-$128.64M
2023-03-31$4.61M$79.42M(m)$129.09M(m)-$131.29M
2022-09-30$2.52M$62.73M(m)$110.96M(m)-$142.31M
2022-06-30$88.97M$57.13M(m)$99.84M(m)-$19.82M
2022-03-31$1.15M$45.94M(m)$79.00M(m)-$89.44M
2021-09-30$5.44M$48.44M(m)$74.64M(m)-$76.09M
2021-06-30$2.84M$36.44M(m)$57.64M(m)-$61.55M
2021-03-31$6.55M$31.56M(m)$47.16M(m)-$47.10M
2020-09-30$41.69M$24.20M(m)$36.50M(m)-$3.17M
2020-06-30$3.59M$21.79M(m)$35.95M(m)-$40.78M
2020-03-31$3.83M$21.74M(m)$34.19M(m)-$39.41M
2019-09-30$6.05M$20.23M(m)$29.98M(m)-$29.57M
2019-06-30$7.14M$24.02M(m)$33.85M(m)-$32.11M
2019-03-31$8.46M$23.55M(m)$32.98M(m)-$29.37M
2018-09-30$10.64M$21.39M(m)$28.55M$0.00-$22.02M
2018-06-30$6.21M$21.58M(m)$29.63M$0.00-$27.52M
2018-03-31$5.27M$22.14M(m)$31.40M$0.00-$30.28M
2017-12-31-$18.00K(m)(m)(m)(m)-$40.48M
2017-09-30$6.18M$24.95M(m)$34.60M$0.00-$32.36M
2017-06-30$3.05M$19.81M(m)$28.25M$0.00-$29.08M
2017-03-31$4.15M$19.29M(m)$27.40M$0.00-$25.87M
2016-12-31$33.14M(m)(m)(m)(m)$7.16M
2016-09-30$59.05M$17.86M(m)$25.08M$0.00$33.36M
2016-06-30$5.80M$9.72M(m)$16.81M$0.00-$11.61M
2016-03-31$8.42M$13.53M(m)$20.38M$0.00-$12.46M
2015-12-31$9.76M(m)(m)(m)(m)-$9.23M
2015-09-30$7.95M$11.56M(m)$16.83M$0.00-$8.85M
2015-06-30$6.54M$12.64M(m)$17.13M$0.00-$10.55M
2015-03-31$4.41M$8.96M(m)$13.32M$0.00-$8.87M
2014-12-31$21.76M(m)(m)(m)(m)$8.44M
2014-09-30$9.41M$11.42M(m)$15.41M$0.00-$5.97M
2014-06-30$7.79M$11.74M(m)(m)$0.00-$8.37M
2014-03-31$7.98M$12.49M(m)(m)$0.00-$8.74M
2013-12-31$24.35M(m)(m)(m)(m)$6.53M
2013-09-30$4.47M$13.45M(m)(m)(m)-$12.59M
2013-06-30$1.01M$12.35M(m)(m)(m)-$15.04M
2013-03-31$821.00K$9.83M(m)(m)(m)-$12.62M
2012-12-31$2.18M(m)(m)(m)(m)-$11.46M
2012-09-30$1.71M$8.80M(m)(m)(m)-$10.04M
2012-06-30$1.84M$8.24M(m)(m)(m)-$8.94M
2012-03-31$1.82M$8.74M(m)(m)(m)-$9.93M
2011-12-31$757.00K(m)(m)(m)(m)-$11.88M
2011-09-30$1.43M$8.89M(m)(m)(m)-$10.64M
2011-06-30$1.05M$10.51M(m)(m)(m)-$13.63M
2011-03-31$763.00K$9.18M(m)(m)(m)-$11.71M
2010-09-30$394.00K$9.55M(m)(m)-$176.00K-$12.34M
2010-06-30$462.00K$10.24M(m)(m)(m)-$13.14M

Revenue and expense 6 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$47.98M$193.33M$209.29M$410.77M(m)-$404.79M
2025-06-30$68.35M$208.40M$123.09M$335.49M(m)-$295.75M
2024-06-30$1.08M$161.17M(m)$257.49M(m)-$278.96M
2023-06-30$5.48M$162.62M(m)$252.00M(m)-$259.93M
2022-06-30$90.12M$103.06M(m)$178.85M(m)-$109.27M
2021-06-30$9.39M$68.00M(m)$104.80M(m)-$108.66M
2020-06-30$7.42M$43.53M(m)$70.14M(m)-$80.19M
2019-06-30$15.60M$47.56M(m)$66.83M(m)-$61.48M
2018-06-30$11.48M$43.72M(m)$61.03M$0.00-$57.80M
2017-06-30$7.21M$39.10M(m)$55.65M$0.00-$54.95M
2016-06-30$14.22M$23.26M(m)$37.19M$0.00-$24.07M
2015-06-30$10.96M$21.59M(m)$30.45M$0.00-$19.42M
2014-06-30$15.77M$24.23M(m)(m)$0.00-$17.12M
2013-06-30$1.83M$22.18M(m)(m)(m)-$27.66M
2012-06-30$3.66M$16.99M(m)(m)(m)-$18.87M
2011-06-30$1.82M$19.69M(m)(m)(m)-$25.34M
2010-06-30$1.08M$19.30M(m)(m)(m)-$25.33M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$70.28M$311.63M$504.18M(m)-$601.92M
2024-09-30$1.55M$245.78M$398.75M(m)-$439.51M
2023-09-30$5.86M$245.15M$374.64M(m)-$389.35M
2022-09-30$92.63M$165.79M$289.80M(m)-$251.57M
2021-09-30$14.83M$116.44M$179.44M(m)-$184.74M
2020-09-30$49.11M$67.73M$106.64M(m)-$83.36M
2019-09-30$21.66M$67.79M$96.82M(m)-$91.05M
2018-09-30$22.12M$65.86M$89.58M$0.00-$79.82M
2017-09-30$13.39M$64.05M$90.25M$0.00-$87.31M
2016-09-30$73.27M$41.12M$62.27M$0.00$9.30M
2015-09-30$18.90M$33.15M$47.29M$0.00-$28.27M
2014-09-30$25.18M$35.65M$48.36M$0.00-$23.09M
2013-09-30$6.30M$35.63M(m)(m)-$40.25M
2012-09-30$5.38M$25.79M(m)(m)-$28.91M
2011-09-30$3.24M$28.58M(m)(m)-$35.98M
2010-09-30$1.48M$28.85M(m)-$176.00K-$37.67M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$88.04M$416.03M$700.30M$0.00-$784.96M
2024-12-31$18.47M$339.41M$554.72M$0.00-$589.53M
2023-12-31$7.53M$330.12M$503.74M$0.00-$526.24M
2022-12-31$94.59M$240.81M$418.79M$0.00-$388.95M
2021-12-31$70.43M$159.94M$256.74M$0.00-$215.31M
2020-12-31$55.83M$96.95M$149.77M$0.00-$127.29M
2019-12-31$26.87M$86.13M$125.73M$0.00-$121.69M
2018-12-31$31.50M$89.14M$120.42M$0.00-$106.29M
2017-12-31$13.37M$90.30M$126.76M$0.00-$127.79M
2016-12-31$106.41M$59.90M$87.72M$0.00$16.45M
2015-12-31$28.66M$46.40M$66.06M$0.00-$37.50M
2014-12-31$46.94M$44.43M$61.69M$0.00-$14.65M
2013-12-31$30.65M$49.45M$64.54M$0.00-$33.72M
2012-12-31$7.56M$35.64M(m)$0.00-$40.37M
2011-12-31$4.00M$37.18M(m)$0.00-$47.86M
2010-12-31$2.58M$38.01M(m)-$176.00K-$49.29M
2009-12-31$81.54M$39.84M(m)$150.00K$24.54M
2008-12-31(m)(m)(m)(m)-$56.37M
2007-12-31(m)(m)(m)(m)-$48.89M
2006-12-31(m)(m)(m)(m)-$57.12M
2005-12-31(m)(m)(m)(m)-$42.25M
2004-12-31(m)(m)(m)(m)-$37.20M
2003-12-31(m)(m)(m)(m)-$32.69M
2002-12-31(m)(m)(m)(m)-$23.08M
2001-12-31(m)(m)(m)(m)-$15.87M
2000-12-31(m)(m)(m)(m)-$13.08M
1999-12-31(m)(m)(m)(m)-$7.34M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Alkermes plc. (ALKS)$6.844B132.74